Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China
BackgroundThe National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the i...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2025-11-01
|
| 叢編: | Frontiers in Public Health |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1705030/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|